<DOC>
	<DOCNO>NCT00666367</DOCNO>
	<brief_summary>This project aim explore relationship Vitamin D deficiency COPD progression via prospective randomize placebo-controlled study . For purpose , study power 120 patient hospitalized exacerbation COPD randomly assign monthly oral dose Vitamin D versus placebo . Taking account dropout , 182 patient randomized course study</brief_summary>
	<brief_title>Vitamin D Treatment Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>Principal objective : To define therapeutic effect Vitamin D chronic maintenance treatment COPD mean prospective randomize placebo-controlled double blind study 182 patient follow-up least one year . Primary endpoint median time next exacerbation . Secondary endpoint total number exacerbation per group , number exacerbation per patient per year , percentage patient one exacerbation per year , day antibiotics oral steroid , quality life , FEV1 , muscle force survival . Other objective : First , investigate role local systemic level 25-OHD 1,25- ( OH ) 2D intensity prevalence bacterial colonisation , inflammatory marker , proteases marker oxidative stress induce sputum exhale air . Second , explore whether correction Vitamin D deficiency oral supplementation Vitamin D trigger VDR-mediated cathelicidin pathway increase local systemic concentration natural antimicrobial polypeptide cathelicidin enhance eradication bacteria .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Primary diagnosis COPD exacerbation Smoking history least ten pack year GOLD stage II , III IV assess postbronchodilator spirometry Informed consent Tiffeneau index &gt; 70 % FEV1 &gt; 80 % Hypercalcemia Sarcoidosis Newly discover symptomatic osteoporosis ( proven DEXA RX ) Active cancer</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>COPD</keyword>
</DOC>